40
Pharma & HealthcareAvoid
Tata India Pharma & Healthcare
Tata · Direct–Growth · rank #12 of 19 by Smart Score
Data updated
Trailing returns
1 Year
10.7%
+10.0% vs index
3 Years
18.4%
+6.8% vs index
5 Years
15.8%
+5.7% vs index
Since launch
13.5%
Year-by-year performance
2021
+20.9%-9.8% vs index
2022
-6.6%-10.4% vs index
2023
+38.6%+12.1% vs index
2024
+42.5%+26.8% vs index
2025
-3.5%-11.1% vs index
2026
+12.7%+11.8% vs index
Why this score
Tata India Pharma & Healthcare scores 40/100 — #12 of 19 Pharma & Healthcare fund (Avoid). It stands out for volatility and alpha — beating 78% of peers on volatility. The main drag is its 3y return (better than only 13% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
3Y return18.36% · 13th percentile in category
5Y return15.79% · 35th percentile in category
Volatility13.36 · 78th percentile in category
Alpha7.81 · 78th percentile in category
1Y return10.71% · 9th percentile in category
Fund size1499.15 Cr · 66th percentile in category
Top holdings
1.Sun Pharmaceutical Industries Ltd7.89%
2.Abbott India Ltd5.66%
3.Divi's Laboratories Ltd5.41%
4.Healthcare Global Enterprises Ltd5.25%
5.Dr. Reddy's Laboratories Ltd5.14%
40 disclosed equity positions · portfolio as of Oct 2026 · weights are % of total corpus.